Cagrilintide lowers bodyweight through brain amylin receptors 1 and 3 eBioMedicine Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial ScienceDirect Semaglutide, a glucagon like peptide 1 (GLP 1) receptor agonist, has well established weight loss benefits. Cagrilintide, a long acting analogue of the satiety hormone amylin, has shown promise for weight loss in early trials. The potential benefit Cagrilintide: Effective Weekly Dosage and Weight Loss Benefits Explained Cagrilintide: The Next Big Thing in Fat Loss or Just Hype? : r BoldReseachPeptides Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial The Lancet